Precision Medicine Group Announces Key Leadership Appointments
Karl Deonanan appointed Chief Financial Officer
Matt DeZee named to newly established role, Chief Transformation and Strategy Officer
Bethesda, Md., October 23, 2024—Precision Medicine Group (Precision), a leading next-generation provider of drug development and commercialization services, today announced key leadership changes to support its next phase of growth. This includes the appointment of Karl Deonanan as Chief Financial Officer (CFO). Mr. Deonanan succeeds Matt DeZee, who has served as CFO of Precision since 2020 and will be transitioning to the newly created role of Chief Transformation and Strategy Officer (CTSO), effective immediately.
Precision Medicine Group Welcomes Margaret Keegan as CEO
— Founding CEO Mark Clein named Executive Chairman; Mr. Clein and co-founder Ethan Leder to continue as Board Directors —
BETHESDA, MD., October 1, 2024 – Precision Medicine Group (Precision), a leading next-generation provider of drug development and commercialization services, today announced the appointment of Margaret Keegan as Chief Executive Officer (CEO) and member of the Board of Directors, effective immediately. Ms. Keegan succeeds Mark Clein, who is assuming the role of Executive Chairman. Mr. Clein co-founded Precision in 2012 as CEO and, together with co-founder Ethan Leder, purpose-built Precision to capitalize on the scientific and technological innovations that are transforming drug development and enabling widespread access to new, breakthrough therapies. Mr. Leder formerly served as Executive Chairman and will remain a member of the Board of Directors.
Now Available On Demand: Cell & Gene Day, 2024
Cell and gene therapies are at a pivot point. These breakthrough therapies show big promise — but the business models to support these new advances are racing to catch up with the science. Can we keep up the pace in the current climate? Find out at Cell & Gene Day 2024, a free virtual event, WATCH ON DEMAND HERE.
Conference: Meeting on the Med, 2024
Precision will be at this year’s Meeting on the Med, April 9-11, 2023, in Rome, Italy. Connect with our team of experts as they lead meaningful presentations and discussions throughout this event providing insights into the clinical development, manufacturing, and commercialization for cell and gene therapies.
Connect with our Advanced Therapy experts
- Visit us through any of the numerous networking opportunities at Meeting on the Med 24′
- Be sure to attend the Precision sponsored workshop on April 9, 2024, at 5:15 PM CET |Location: Rome Cavalieri, A Waldorf Astoria Hotel
You can register for Meeting on the Med below:
Conference: Gene Therapy for Rare Disorders (GTRD), 2024
Precision will be at this year’s Gene Therapy for Rare Disorders on March 26-29, 2024, in Boston, MA. Connect with our team of experts as they lead meaningful presentations and discussions throughout this event providing insights into the clinical development, manufacturing, and commercialization for gene therapies.
Speaking Engagements
Detailed descriptions for each speaking engagement are included below.
- Precision will have a plenary speaking position on March 27, 2024, 8:30 – 9:00 am.
- Precision’s Andy Kinley (VP, Innovation & Clinical Science, Precision for Medicine) will Chair the Clinical track session, “Clinical Endpoints for Rare Disease Studies,” on March 28, 2024, 11:15 am – 12:15 pm.
Connect with our Advanced Therapy experts
- Schedule in-person or virtual meetings with our team
—
Plenary Speaking Position: What to Look Forward to for Gene Therapy in 2024
Precision | March 27, 2024, 8:30 – 9AM ET
- Key Takeaways
- Market trends and expectations for Gene Therapies & Rare Diseases in 2024
- Predictions on Potential Approvals in 2024
- Innovative Trends & Technologies
- Evolution of CMC and manufacturing
Speakers:
- [Moderator] Jake Greenwood, VP, Project Farma
- Faraz Ali, CEO, Tenaya Therapeutics
- Debs Phippard, CSO, Precision for Medicine
- Frank Bugg, Global Head of BaseCamp Operations & Commercial, ElevateBio
Panel Discussion: Manufacturing Track: Capacity versus Capability – Moving Towards Innovative Manufacturing Processes
Precision | March 28, 2024, 11:15AM – 12:15PM ET
- Andy Kinley, VP, Innovation & Clinical Science (Precision for Medicine) to Chair